Risky business: re-evaluating participant risk in biobanking<sup>1</sup>

Nils Hoppe

in Human Tissue Research

Published in print March 2011 | ISBN: 9780199587551
Published online May 2011 | e-ISBN: 9780191725630 | DOI:
Risky business: re-evaluating participant risk in biobanking1

More Like This

Show all results sharing this subject:

  • Public Health and Epidemiology


Show Summary Details


Participation in research and therapy in most cases entails a certain degree of risk for the participants. Traditionally, the notion of risk in this setting has been taken to mean risk of physical harm that may result. A variable yardstick of the level of permissible risk has been used in the past to determine an individual's ability to consent validly to their participation. In the area of research using biobanks (i.e., organized collections of biological samples and various forms of associated data, including, but not limited to, genetic data), the conventional notions of risk may have to be reconsidered in the light of informational, psychiatric, economic, and social risks. This chapter addresses the different dimensions in relation to risk models which may have to be re-evaluated in the context of biobanking.

Keywords: biobanking; risk; genetic data; ethics; law; consent; medical data

Chapter.  5620 words. 

Subjects: Public Health and Epidemiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.